The importance of a valid assessment of salt intake in individuals and populations. A scientific statement of the British and Irish Hypertension Society

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2


  1. 1.

    Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. Effect of lower sodium intake on health: systematic review and meta-analyses. Br Med J. 2013;346:f1326.

  2. 2.

    He FJ, MacGregor GA. Salt reduction lowers cardiovascular risk: meta-analysis of outcome trials. Lancet. 2011;378:380–2.

  3. 3.

    Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129:981–9.

  4. 4.

    O’Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371:612–23.

  5. 5.

    O’Donnell MJ, Yusuf S, Mente A, Gao P, Mann JF, Teo K, et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA. 2011;306:2229–38.

  6. 6.

    Mente A, O’Donnell MJ, Rangarajan S, Matthew J, McQueen MJ, Poirier P, et al. Association of urinary sodium and potassium excretion with blood pressure. N Engl J Med. 2014;371:601–11.

  7. 7.

    Mente A, O’Donnell M, Rangarajan S, Dagenais G, Lear S, McQueen M, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388:465–75.

  8. 8.

    Mente A, O’Donnell M, Rangarajan S, McQueen M, Dagenais G, Wielgoz A, et al. Urinary sodium excretion, blood pressure, cardiovascular disease, and mortality: a community-level prospective epidemiological cohort study. Lancet. 2018;392:496–506.

  9. 9.

    O’Donnell M, Mente A, Rangarajan S, McQueen MJ, O’Leary N, Yin L, et al. Joint association of urinary sodium and potassium excretion with cardiovascular events and mortality: prospective cohort study. Br Med J. 2019;364:I772.

  10. 10.

    World Health Organization. Guideline: sodium intake for adults and children. Geneva: World Health Organization; 2012. p. 1–46.

  11. 11.

    Cobb LK, Anderson CA, Elliott P, Hu FB, Liu K, Neaton JD, et al. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation. 2014;129:1173–86.

  12. 12.

    Cappuccio FP, Beer M, Strazzullo P. on behalf of the European Salt Action Network. Population dietary salt reduction and the risk of cardiovascular disease. A scientific statement from the European Salt Action Network. Nutr Metab Cardiovasc Dis. 2019;29:107–14.

  13. 13.

    McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Campbell NRC. Assessment of dietary sodium intake using a food frequency questionnaire and 24-hour urinary sodium excretion: a systematic literature review. J Clin Hypertens. 2017;19:1214–30.

  14. 14.

    McLean RM, Farmer VL, Nettleton A, Cameron CM, Cook NR, Woodward M, et al. Twenty‐four-hour diet recall and diet records compared with 24‐hour urinary excretion to predict an individual’s sodium consumption: a systematic review. J Clin Hypertens. 2018;20:1360–76.

  15. 15.

    Lucko AM, Doktorchick C, Woodward M, Cogswell M, Neal B, Rabi D, et al. Percentage of ingested sodium excreted in 24-hour urine collections: a systematic review and meta-analysis. J Clin Hypertens. 2018;20:1220–9.

  16. 16.

    Lerchl K, Rakova N, Dahlmann A, Rauh M, Goller U, Basner M, et al. Agreement between 24-hour salt ingestion and sodium excretion in a controlled environment. Hypertension. 2015;66:850–7.

  17. 17.

    Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, et al. Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA. 2016;315:2200–10.

  18. 18.

    Cook NR, Appel LJ, Whelton PK. Sodium intake and all-cause mortality over 20 years in the trials of hypertension prevention. J Am Coll Cardiol. 2016;68:1609–17.

  19. 19.

    Olde Engberink RHG, van den Hoek TC, van Noordenne ND, van den Born BH, Peters-Sengers H, Vogt L. Use of a single baseline versus multiyear 24-hour urine collection for estimation of long-term sodium intake and associated cardiovascular and renal risk. Circulation. 2017;136:917–26.

  20. 20.

    Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharm Physiol. 1993;20:7–14.

  21. 21.

    He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47:1784–95.

  22. 22.

    Swanepoel B, Schutte AE, Cockeran M, Steyn K, Wentzel-Viljoen E. Monitoring the South African population’s salt intake: spot urine v. 24 h urine. Public Health Nutr. 2018;21:480–8.

  23. 23.

    Cappuccio FP, D'Elia L. Evaluating population salt reduction programmes worldwide: the risk of cutting corners! Public Health Nutr. 2018;21:2161–3.

  24. 24.

    Huang L, Woodward M, Stepien S, Tian M, Yin X, Hao Z, et al. Spot urine samples compared with 24-h urine samples for estimating changes in urinary sodium and potassium excretion in the China Salt Substitute and Stroke Study. Int J Epidemiol. 2018;47:1811–20.

Download references

Author information

Ethics declarations

Conflict of interest

FPC is a technical advisor to the World Health Organization, President and Trustee of the British and Irish Hypertension Society. PSS declares that he has no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark